In rats given BPC-157, serotonin levels in the brain increase in specific regions while simultaneously decreasing in other regions, such as the hippocampus.[ref] A 2020 study found that BPC-157 reduced leaky gut syndrome by stabilizing gut permeability after NSAID use.[ref] Reducing leaky gut theoretically can affect the gut-brain axis and reduce inflammation
By mimicking the bodys endogenous GLP-1, these drugs suppress appetite, slow gastric emptying, and influence reward mechanisms in the brain
Journal of the International Society of Sports Nutrition, 22 (Supplement 2)
The cell line has been validated to respond to GIP
How GLP-1 receptor agonists can promote weight loss GLP-1 receptor agonists mimic a natural hormone our intestines release called glucagon-like peptide 1, which can promote weight loss via three actions: Suppressing appetite "The drugs 'talk' to our brain to encourage us to eat less and to be less preoccupied with food," explains Alexandra Sowa, MD , a dual board-certified obesity and internal medicine physician practicing in New York City, a clinical instructor of medicine at New York University, and author of The Ozempic Revolution